More than five dozen medical device, diagnostic, and digital health startups have been selected for the 2024 MedTech Innovator accelerator program.
The startups include two companies interviewed by Medical Design & Outsourcing in the past year: Flow Medical and The Shape Sensing Co.
“Our accelerator has become the gold standard, thanks to our industry-leading track record of identifying and refining the most innovative medtech startups in the world,” MedTech Innovator founder and CEO Paul Grand said in a news release. “Since launching MedTech Innovator, our more than 600 graduates have received 310 FDA approvals and clearances and secured $8 billion in follow-on funding.”
Approximately 1,300 startups applied for this year’s program. Major medtech firms including Asahi Intecc, BD, Dexcom, Edwards Lifesciences, Johnson & Johnson, NIPRO, Olympus, W. L. Gore & Associates and Zimmer Biomet helped narrow the pool down to this year’s class of 65 startups.
They’ll compete for $800,000 in nondilutive funding at the end of the four-month program.
“Having evaluated thousands of applicants since November, I can tell you definitively that the 2024 MedTech Innovator Cohort represents the best emerging startups around the globe,” Grand said. “We are excited to spend the next four months with our industry-leading corporate partners and industry experts, to help these entrepreneurs advance their medical device, diagnostic and digital health innovations to improve the lives of millions.”
The 2024 MedTech Innovator cohort startups are:
- AccurKardia – New York City
- Acorai – Helsingborg, Sweden
- Akeyna – Boston
- Arsenal Medical – Waltham, Massachusetts
- Astek Diagnostics – Baltimore, Maryland
- ATDev – Los Angeles
- Aurie – Syracuse, New York
- Avance Innovations – London
- BrainSpace – Seattle
- Butterfly Medical – Yokneam, Israel
- CardioSignal – Turku, Finland
- Cellular Vehicles – San Mateo, California
- Craif – Tokyo
- CranioSense – Boston
- Cyted Health – Cambridge, United Kingdom
- CytoVeris – Farmington, Connecticut
- DiaMonTech – Berlin, Germany
- Dopl Technologies – Seattle
- Droplet IV – Copenhagen, Denmark
- Endo-TAGSS – Shawnee, Kansas
- Fasciotens – Cologne, Germany
- FemTherapeutics – Montreal, Canada
- FibriCheck – New York City
- Flow Medical – Chicago
- HealthTech Connex – Surrey BC, Canada
- iCE Neurosystems – Washington, D.C.
- INIA Biosciences – Boston
- Innova Vascular – Irvine, California
- Invicta Medical – Santa Clara, California
- Juniper Biomedical – Worcester, Massachusetts
- Laguna Tech USA – Irvine, California
- LaNua Medical – Dublin, Ireland
- LATTICE MEDICAL – Loos, France
- Ligence – Kaunas, Lithuania
- myBiometry – Boston
- Nanobiofab – Frederick, Maryland
- NANOCHON – Washington, D.C.
- NeuroBionics – Cambridge, Massachusetts
- Neuspera Medical – San Jose, California
- Nurami Medical – Haifa, Israel
- Ortho-tag – Palm Beach Gardens, Florida
- Orthomod – Dayton, Ohio
- Ozlo – Boston
- Paxos Medical – Minneapolis
- Plexaa – London
- Prevencio – Kirkland, Washington
- ReConstruct Bio – Boston
- Relief Cardiovascular – Costa Mesa, California
- Remedi – Seoul, Korea
- Robeauté – Paris
- Salvia BioElectronics – Eindhoven, The Netherlands
- Samay – Mountain View, California, and Medellín, Colombia
- SanaHeal – Cambridge, Massachusetts
- SmartCardia – Lausanne, Switzerland
- Solenic Medical – Addison, Texas
- Somnics Health – Redwood City, California
- Spiorad Medical – Dublin, Ireland
- Summa Therapeutics – Cambridge, Massachusetts
- Surgical Automations – Dallas
- SwiftDuct – Sakhnin, Israel
- Taurus Vascular – Houston
- The Shape Sensing Company – Austin, Texas
- TYBR Health – Houston
- Vonova – San Diego
- X-Bolt Orthopedics – Dublin, Ireland
